Corcept Therapeutics (CORP) stock plummeted 48% in its worst intraday performance in 11 years, signaling a potential fundamental crisis at the company.
The Nasdaq Golden Dragon China Index opened down 0.76%, dragged lower by a sharp sell-off in Chinese electric vehicle manufacturers, with NIO declining by 5%.
On December 31, Shandong Zhanggu Blower disclosed it is under investigation by the China Securities Regulatory Commission for suspected illegal financial reporting.
Edgen Stock·Dec 19 2025, 22:43Edgen Stock·Dec 19 2025, 22:43
Edgen Stock·Dec 19 2025, 22:43
